Early alpha‐foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma

医学 肝细胞癌 内科学 危险系数 胃肠病学 置信区间 实体瘤疗效评价标准 肿瘤科 化疗 进行性疾病
作者
Yu‐Yun Shao,Tsung‐Hao Liu,Chiun Hsu,Li-Chun Lü,Yin‐Chung Shen,Zhong‐Zhe Lin,Ann‐Lii Cheng,Chih‐Hung Hsu
出处
期刊:Liver International [Wiley]
卷期号:39 (11): 2184-2189 被引量:72
标识
DOI:10.1111/liv.14210
摘要

Abstract Background Post‐treatment decline in serum alpha‐foetoprotein (AFP) levels has been shown to predict the treatment efficacy of antiangiogenic therapy for advanced hepatocellular carcinoma (HCC). We explored whether a decline in AFP levels was also associated with treatment outcomes of immune checkpoint inhibitors (ICIs) in patients with advanced HCC. Methods We reviewed all patients who received ICI therapy for advanced HCC. AFP response was evaluated in patients with the pretreatment AFP level of >20 ng/mL. We defined early AFP response as a >20% decline in serum AFP levels within the first 4 weeks of treatment initiation relative to pretreatment levels. We then studied whether early AFP response was associated with treatment outcomes. Results Sixty patients were enrolled in this study; 43 of them were evaluable for early AFP response. The objective response rate of early AFP responders was significantly higher than that of early AFP nonresponders (73% vs. 14%, P < .001). Early AFP responders, compared with early AFP nonresponders, exhibited significantly longer overall survival (OS) (median, 28.0 vs 11.2 months, P = .048) and progression‐free survival (PFS) (median, 15.2 vs 2.7 months, P = .002). After adjusting for other clinicopathological variables and treatments, early AFP response remained an independent predictor for longer OS (hazard ratio [HR] = 0.089, 95% confidence interval [CI] = 0.018‐0.441; P = .003) and PFS (HR = 0.128, 95% CI = 0.041‐0.399; P < .001). Conclusion Early AFP response was associated with higher treatment efficacy of ICIs for advanced HCC. Additional validation studies are nonetheless warranted.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
2秒前
谜记完成签到,获得积分10
2秒前
共享精神应助Cheung2121采纳,获得30
2秒前
光撒盐完成签到,获得积分10
3秒前
cowboy007完成签到,获得积分10
3秒前
张振宇完成签到 ,获得积分10
4秒前
zz发布了新的文献求助10
5秒前
zzq778发布了新的文献求助10
7秒前
黄怡婷完成签到 ,获得积分10
7秒前
Daisy应助科研通管家采纳,获得10
8秒前
机智苗应助科研通管家采纳,获得10
8秒前
香蕉觅云应助科研通管家采纳,获得10
8秒前
FashionBoy应助科研通管家采纳,获得10
8秒前
赘婿应助科研通管家采纳,获得10
8秒前
大模型应助科研通管家采纳,获得10
8秒前
yanmu2010应助科研通管家采纳,获得10
8秒前
kingwill应助科研通管家采纳,获得20
9秒前
银包铜应助科研通管家采纳,获得10
9秒前
共享精神应助科研通管家采纳,获得10
9秒前
9秒前
情怀应助科研通管家采纳,获得10
9秒前
李爱国应助科研通管家采纳,获得10
9秒前
所所应助科研通管家采纳,获得10
9秒前
9秒前
Orange应助科研通管家采纳,获得10
9秒前
9秒前
9秒前
Lucas完成签到,获得积分10
11秒前
C胖胖完成签到,获得积分10
11秒前
舒心的完成签到,获得积分10
11秒前
zz完成签到,获得积分10
12秒前
13秒前
13秒前
13秒前
14秒前
luozejun完成签到,获得积分10
14秒前
ycp完成签到,获得积分10
15秒前
dawang完成签到 ,获得积分10
15秒前
洁净的智宸完成签到 ,获得积分10
15秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038368
求助须知:如何正确求助?哪些是违规求助? 3576068
关于积分的说明 11374313
捐赠科研通 3305780
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029